 | Lexaria Bioscience Corp.: Lexaria Summarizes Successful Antiviral Drug Studies and Ongoing Strategy
finanznachrichten.de - July 24 at 11:25 PM |
| Lexaria Bioscience Corp.: Lexaria's DehydraTECH Significantly Enhances Delivery of Colchicine in Study VIRAL-A20-3
finanznachrichten.de - July 22 at 11:36 PM |
 | Lexaria Summarizes Successful Antiviral Drug Studies and Ongoing Strategy
finance.yahoo.com - July 22 at 8:35 AM |
| Lexaria's DehydraTECH Significantly Enhances Delivery of Colchicine in Study VIRAL-A20-3
finance.yahoo.com - July 21 at 9:12 AM |
| Lexaria Bioscience Corp.: Lexaria Completes Successful Antiviral Drug Molecular Characterization Study With Canada's National Research Council
finanznachrichten.de - July 16 at 7:03 PM |
| Lexaria Announces Voluntary Delisting from the Canadian Securities Exchange to Concentrate Trading on the Nasdaq Capital Markets
finance.yahoo.com - July 5 at 12:57 PM |
| Lexaria Hits Important Anti-Viral Milestone with In Vitro Test of DehydraTECH(TM)
finance.yahoo.com - June 17 at 12:30 PM |
| Lexaria Bioscience Corp.: Lexaria Provides Progress Report on Six R&D Programs
finanznachrichten.de - June 9 at 8:59 AM |
|
| Lexaria Provides Progress Report on Six R&D Programs
finance.yahoo.com - June 9 at 8:59 AM |
| Lexaria Bioscience Corp.: Lexaria Issues Progress Report on First Human Clinical Study of 2021, HYPER-H21-1
finanznachrichten.de - June 7 at 9:02 AM |
| Lexaria Issues Progress Report on First Human Clinical Study of 2021, HYPER-H21-1
finance.yahoo.com - June 7 at 9:02 AM |
 | Lexaria Bioscience on Drug Delivery Technology and its Patented DehydraTECH
benzinga.com - June 3 at 12:31 PM |
| Lexaria's DehydraTECH(TM)-Enabled Remdesivir and Ebastine Effectively Inhibit the COVID-19 SARS-CoV-2 Virus
finance.yahoo.com - June 3 at 7:30 AM |
| Lexaria's Newest DehydraTECH(TM) 2.0 Formulation Tested in Study HYPER-A21-2 Demonstrates Its Strongest CBD Absorption Results Ever
finance.yahoo.com - May 20 at 7:28 AM |
| Lexaria Bioscience Corp.: Lexaria Strengthens Its International Patent Portfolio to 19 Patents Granted
finanznachrichten.de - May 12 at 7:57 AM |
| Lexaria Strengthens Its International Patent Portfolio to 19 Patents Granted
finance.yahoo.com - May 12 at 7:57 AM |
| Lexaria to Present at the Benzinga Global Small Cap Conference on May 13, 2021 at 3:50 p.m. ET
finance.yahoo.com - May 7 at 1:45 PM |
| Lexaria Bioscience Corp. Discusses Potential of DehydraTECH(TM) CBD for Revolutionary Hypertension Solution with The Stock Day Podcast
finance.yahoo.com - May 7 at 1:45 PM |
| Lexaria Bioscience Corp.: Lexaria Issues Successful Results from First 2021 Study, HYPER-A21-1
finanznachrichten.de - May 6 at 7:38 AM |
| BTV Explores Investment Options in Life Sciences
finance.yahoo.com - May 6 at 7:38 AM |
| Lexaria Issues Successful Results from First 2021 Study, HYPER-A21-1
finance.yahoo.com - May 6 at 7:38 AM |
| Lexaria Bioscience Corp., Proprietary Drug Delivery Technology, CEO Clip Video
finance.yahoo.com - April 27 at 5:37 PM |
 | Lexaria's Dehydration Technology Makes CBD Treatment More Efficient
seekingalpha.com - April 24 at 9:52 AM |
 | We Think Lexaria Bioscience (NASDAQ:LEXX) Can Afford To Drive Business Growth
nasdaq.com - April 23 at 11:30 PM |
|
| Lexaria Commences Human Clinical Hypertension Study
finance.yahoo.com - April 22 at 8:01 AM |
| We're Hopeful That Lexaria Bioscience (NASDAQ:LEXX) Will Use Its Cash Wisely
finance.yahoo.com - April 20 at 1:30 PM |
 | The Daily Biotech Pulse: Precision Biosciences Regains Rights To CAR T Candidates, CFO Changes, 2 IPOs
markets.businessinsider.com - April 16 at 8:41 AM |
 | NA Proactive news snapshot: Lexaria Bioscience, New Pacific Metals, HempFusion Wellness, Gevo, Information Services Corporation UPDATE
proactiveinvestors.com - April 15 at 7:11 PM |
| Lexaria Bioscience: Turning the Tide on Hypertension
finance.yahoo.com - April 15 at 9:10 AM |
| Lexaria's DehydraTECHTM Technology Utilized in Amari's "Everyday Calm," Named a Top CBD Product Pick by New Hope Network
finance.yahoo.com - April 14 at 9:57 AM |
| Lexaria Is Expanding CBD Use Beyond Medical Applications into $2.65 Billion Marketplace
finance.yahoo.com - April 8 at 9:41 AM |
| Lexaria Bioscience to evaluate DehydraTECH in four drug markets
proactiveinvestors.com - April 6 at 12:34 PM |
| Lexaria Bioscience Corp.: Lexaria to Evaluate DehydraTECH in Multiple New Markets
finanznachrichten.de - April 6 at 7:34 AM |
| Lexaria to Evaluate DehydraTECH(TM) in Multiple New Markets
finance.yahoo.com - April 6 at 7:34 AM |
| Lexaria Technology Generates Positive Stability Testing for World-Class Ready-to-Drink CBD Beverages
finance.yahoo.com - March 24 at 9:06 AM |
| Lexaria to Present at the Benzinga Biotech Small Cap Conference on March 24, 2021 at 9:45 AM ET
finance.yahoo.com - March 23 at 8:03 AM |
| Lexaria Bioscience reports progress in two antiviral drug studies in its 2021 applied R&D program
proactiveinvestors.com - March 17 at 2:32 PM |
| Lexaria's Antiviral Drug Evaluation Program Progressing
finance.yahoo.com - March 16 at 8:47 AM |
| Lexaria Bioscience Corp.: Rapid Progress in Hypertension Studies by Lexaria
finanznachrichten.de - March 15 at 7:25 AM |
| Rapid Progress in Hypertension Studies by Lexaria
finance.yahoo.com - March 15 at 7:25 AM |
| Lexaria Bioscience Corp.: Lexaria to Present and Meet with Investors One-on-One at the 33rd Annual Virtual ROTH Conference on March 15-17, 2021
finanznachrichten.de - March 11 at 9:14 AM |
| Lexaria to Present and Meet with Investors One-on-One at the 33rd Annual Virtual ROTH Conference on March 15-17, 2021
finance.yahoo.com - March 11 at 9:14 AM |
| Could DehydraTECH(TM) CBD be Worth $3 Billion a Year to Lexaria?
finance.yahoo.com - March 9 at 1:48 PM |
| Lexaria Bioscience Corp. is Changing the Future of Drug Delivery
finance.yahoo.com - March 2 at 11:56 PM |
 | LEXX.OQ - Lexaria Bioscience Corp Profile | Reuters
reuters.com - February 5 at 5:45 PM |
| Lexaria Bioscience Corp.: Lexaria Provides Guidance on Upcoming R&D
finanznachrichten.de - February 2 at 5:24 PM |
